In vitro assessment of a combination therapy of abametapir and flavesone as a novel topical single-dose scabies treatment
File version
Version of Record (VoR)
Author(s)
Samarawickrama, GR
Nammunige, NA
Hartel, G
Bowles, V
Fischer, K
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
Abstract
Scabies is a highly contagious skin disease with an estimated global annual prevalence of 400 million. The World Health Organisation listed scabies as a neglected tropical disease in 2017, requesting to improve diagnosis, surveillance, and treatments.
Journal Title
Journal of the American Academy of Dermatology
Conference Title
Book Title
Edition
Volume
Issue
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
© 2026 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc. This is an open access article under the CC BY license (http://creativecommons.org/ licenses/by/4.0/).
Item Access Status
Note
This publication has been entered in Griffith Research Online as an advance online version.
Access the data
Related item(s)
Subject
Persistent link to this record
Citation
Fernando, DD; Samarawickrama, GR; Nammunige, NA; Hartel, G; Bowles, V; Fischer, K, In vitro assessment of a combination therapy of abametapir and flavesone as a novel topical single-dose scabies treatment, Journal of the American Academy of Dermatology, 2026